Skip to content
CharitiesAidWelfare, Medical Health Aged Care

MEDIA ALERT – PHOTO OPPORTUNITY

Bowel Cancer Australia < 1 mins read
Bowel Cancer Australia_Call on Canberra

MEDIA ALERT – PHOTO OPPORTUNITY

Youthfulness should not be a barrier to timely diagnosis

 

Where: Forecourt, Parliament House, Canberra

 

When: Tuesday, 20 June at 8.15am

 

What: 50 early-onset bowel cancer patients and medical experts

 

Australians from around the country impacted by early-onset bowel cancer along with medical experts will visit Parliament House to participate in Bowel Cancer Australia’s inaugural Call on Canberra to raise awareness and advocate for important policy change.

 

Latest Australian research reveals younger people with bowel cancer symptoms find self-advocating to be the only consistent and reliable resource for overcoming age bias, barriers to diagnosis, and optimising outcomes for the deadliest cancer in those aged 25-44.

 

  • 1-in-10 new bowel cancer cases are diagnosed in people under age 50 (1,680 annually).

 

  • Bowel cancer is the deadliest cancer for people aged 25-44.

 

  • Over the past three decades there has been a 266% increase in bowel cancer incidence rates in adolescents and young adults (15-24 years).

bowelcanceraustralia.org/early-onset


Contact details:


For an interview with a medical expert or patient contact:
Stephanie Bansemer-Brown – Bowel Cancer Australia
stephanie@bowelcanceraustralia.org   |   0412 915 797

Media

More from this category

  • CharitiesAidWelfare, Community
  • 04/12/2023
  • 11:49
Cana Communities

Sydney charity asks Aussies to support local products this Christmas while providing employment pathways for disadvantaged people

MEDIA RELEASE4 December 2023 Sydney charity asks Aussies to support local products this Christmas while providing employment pathways for disadvantaged people A much-loved farm…

  • Contains:
  • Medical Health Aged Care
  • 04/12/2023
  • 09:52
AbbVie

RINVOQ® (upadacitinib) now reimbursed for Australians living with Severe Crohn’s disease1

RINVOQ®, a once daily tablet, has become available on the Pharmaceutical Benefits Scheme (PBS) for eligible patients living with severe active Crohn’s disease (CD)1,2 It’s the first new molecule for CD to be funded by the Government in seven years1,3 Australia has one of the high rates in the world, impacting many in their 20s to 30s-6 Currently there is no cure for CD and severity of the disease is on the rise due to environmental & dietary factors7,8 SYDNEY, AUSTRALIA, 4 December 2023 – AbbVie (NYSE: ABBV), is pleased to announce RINVOQ® (upadacitinib), a once daily tablet, has been…

  • Medical Health Aged Care
  • 04/12/2023
  • 09:47
For immediate release - December, 4 2023

Survey reveals what’s standing in the way of good health

Aussies are being urged to prioritise their health and wellbeing with research revealing more than 40 per cent feel cost or time pressures are the main barrier standing in their way. With the end of year approaching, Australians are being encouraged to make the most from their health insurance and book any medical appointments they might have forgotten or missed in 2023. The Bupa Pulse Check study also revealed that of the 38 per cent of Australians who say they’re struggling to maintain their health and wellbeing, 50 per cent feel cost was a barrier with the survey also showing…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.